Wed.Mar 26, 2025

article thumbnail

AI in Pharma Marketing: Innovation or Compliance Nightmare?

Pharma Marketing Network

Artificial intelligence (AI) is no longer a futuristic concept in healthcareits here, embedded in nearly every touchpoint of modern pharma marketing. From generative AI tools that draft emails to predictive algorithms that segment target audiences, the speed and scale of innovation are staggering. But as pharma marketers race to adopt these tools, a central question looms: Is AI fueling smarter engagement, or setting the stage for a compliance disaster?

article thumbnail

Trump administration says it will pull back billions in Covid funding from local health departments

STAT

Federal health officials said Tuesday they are pulling back $11.4 billion in COVID-19-related funds for state and local public health departments and other health organizations throughout the nation. “The COVID-19 pandemic is over, and HHS will no longer waste billions of taxpayer dollars responding to a non-existent pandemic that Americans moved on from years ago,” the U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA approves first-in-class oral antibiotic

European Pharmaceutical Review

The US Food and Drug Administration (FDA) has approved Blujepa ( gepotidacin ) antibiotic for uncomplicated urinary tract infections (uUTIs) in female adults and paediatric patients aged 12 years old and over. The first-in-class bactericidal drug is indicated for such infections caused by E scherichia coli, Klebsiella pneumoniae, Citrobacter freundii complex, Staphylococcus saprophyticus and Enterococcus faecalis.

FDA
article thumbnail

Opinion: The neurosurgeon keeping ‘Severance’ (relatively) medically accurate

STAT

On a recent Friday evening, it struck me: I needed to speak to a neurosurgeon. I was watching someone root around in actor Adam Scott’s head on an episode from the second season of “Severance” on Apple TV+. (Note: This post and podcast episode contain spoilers for “Severance.” You’ve been warned.) I needed to know: How realistic is the brain surgery that gives the show its name and premise?

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Could Trump force us to pay more for our medicines? - podcast

The Guardian - Pharmaceutical Industry

Big pharma is eyeing Australias Pharmaceutical Benefits Scheme, as they lobby Donald Trump to demand higher prices for their medicines. Anthony Albanese has promised to bring down the price of PBS-listed medicines to no more than $25 a script, while the Coalition has already pledged to match it if they return to government. Senior reporter Tory Shepherd speaks to Reged Ahmad about the politics of our affordable medicines You can support the Guardian at theguardian.com/fullstorysupport Read more:

article thumbnail

STAT+: Recent pharma-telehealth partnerships feel ‘black boxy,’ and why that’s problematic

STAT

In recent months, a new kind of partnership between telehealth companies and pharmaceutical manufacturers has come under scrutiny over concerns that such arrangements could lead to inappropriate prescriptions and poor care. Eli Lilly and Pfizer, along with five telehealth companies accessible through the pharma companies’ websites, have recently received letters from four senators echoing those concerns, asking questions about care, prescription volume, and the flow of data and money betw

More Trending

article thumbnail

STAT+: Make America Healthy Again is ringing through statehouses across the U.S.

STAT

You’re reading The MAHA Diagnosis , a STAT series that examines the major elements of the Make America Healthy Again movement led by Robert F. Kennedy Jr. From cancer warning labels to soda taxes , progressive states like California and New York have long led the way on legislation meant to improve public health. Now the Make America Healthy Again movement is prompting lawmakers in more conservative states, like Texas, Florida, Oklahoma, and Utah, to join blue ones in introducing bills th

article thumbnail

Gary Lyons appointed as EVP medical affairs of Coronado Research

Pharmafile

Coronado Research, a UK-based consultancy-led organisation, has announced that it has appointed Gary Lyons as executive vice president (EVP) for medical affairs. Lyons is a medical affairs leader, with experience in senior positions in pharmaceutical, consultancy and agency sectors. He has worked on developing medical communication services locally and globally.

article thumbnail

STAT+: Tara Schwetz, who oversaw creation of ARPA-H, placed on leave by NIH 

STAT

The National Institutes of Health on Wednesday placed deputy director Tara Schwetz on administrative leave, according to a source familiar with the decision, marking the third time a senior leader has departed the agency since the Trump administration took power roughly nine weeks ago.  Schwetz had served as deputy director for coordination, planning, and strategic initiatives, a position she has held since late 2023.

article thumbnail

Allegro shares promising preclinical results for osteoarthritis treatment

Pharmafile

Allegro has announced that hydrocelin, its injectable microparticle hydrogel, showed no signs of toxicity in two preclinical studies. Allegro is a biomedical company that develops nanotechnology-based treatments for degenerative joint disease. The preclinical studies were conducted in rats for periods of four and 13 weeks, respectively. Hydrocelin was injected into four separate locations, and a […] The post Allegro shares promising preclinical results for osteoarthritis treatment appeared

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

STAT+: Your questions answered: How insurers are using AI

STAT

Y ou’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine.  Sign up to get it  delivered in your inbox every Wednesday.   My colleague Casey Ross has been reporting on AI in health care since before it was cool (remember IBM’s Watson ?

article thumbnail

Pharming Group doses first patient in phase 2 trial of leniolisib in CVID

Pharmafile

Pharming Group has announced that the first patient has been dosed in a phase 2 clinical trial evaluating leniolisib in common variable immunodeficiency (CVID) patients with immune dysregulation. The company, based in Leiden, the Netherlands, specialises in developing and commercialising medicines for patients with rare, debilitating and life threatening diseases.

article thumbnail

Expert Discusses Role of the Pharmacist in Reproductive Health | APhA 2025

Drug Topics

Jasmine Cutler, PharmD, CPh, assistant professor in the department of pharmacy practice at the Taneja College of Pharmacy, discusses role of education and accessibility in reproductive health.

article thumbnail

Rx-to-OTC rule gets pushed back — again

PharmaVoice

A delay of the prescription-to-OTC rule signals health agencies’ ongoing reluctance to implement new regulations.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Recap: Pharmacists Share The Biggest Takeaways from APhA 2025

Drug Topics

Experts discuss what they learned at the American Pharmacists Association Annual Meeting and Exposition 2025.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

The Centers for Disease Control and Prevention is reportedly rescinding $11.4 billion in funds to states, cities and organizations receiving grants for COVID-19 efforts.

article thumbnail

Q&A: Pharmacy Closures, PBM Reform, and How Pharmacists Can Effectively Advocate

Drug Topics

A conversation with Rob Frankil, RPh, executive director of the Philadelphia Association of Retail Druggists.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

To prepare for the expansion, Two Chairs has added new clinicians to its team, including some who are cross-licensed to treat in multiple states. To date, the company focused on building its presence in California, Florida and Washington, where it also has in-person clinics.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Expert Discusses Critical Role of Technology in Diabetes Care | APhA 2025

Drug Topics

Susan Cornell, PharmD, CDCES, FAPhA, FADCES, associate director of experiential education at the College of Pharmacy at Midwestern University, also addresses personalized care and the expanding responsibilities of pharmacists.

article thumbnail

Thrombosis, Major Bleeding Events More Frequent in Myelofibrosis Compared With Other Myeloproliferative Neoplasms

Pharmacy Times

Using Janus kinase inhibitors, having experienced a previous thrombosis episode, and higher age were associated with a heightened risk of a new thromboembolic event.

article thumbnail

Character raises $93m for eye drugs, plus other financings

pharmaphorum

Recent financings in the biotech space include rounds for Character Bio, Tempero, Epicrispr, Hillstar Bio, and Ampersand Biomedicines

article thumbnail

Interplay of Community, Treatment, and Patient Factors Critical for Improving Joint Outcomes in Severe Hemophilia

Pharmacy Times

Older age and being insured with Medicare or Medicaid were associated with heightened annual joint bleeding rates, whereas treatment in the Northeast United States improved outcomes in both hemophilia A and hemophilia B.

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Private equity's track record in healthcare could best be described as "mixed," with high-profile failures like the implosion of Steward Health Care setting a poor example. | Private investment will be even more critical for healthcare organizations in a political environment where public funds are likely to shrink.

article thumbnail

AIM Test Could Help Predict COVID-19 Vaccine Response in Patients With CLL

Pharmacy Times

Patients with chronic lymphocytic leukemia (CLL) show weakened T-cell memory responses to COVID-19 vaccination.

article thumbnail

FDA fast tracks Sanofi’s mRNA vaccine for chlamydia

Pharmaceutical Technology

Sanofi will commence a Phase I/II trial with its vaccine candidate in the next few days to start generating immunogenicity data.

article thumbnail

Researchers Identify Key Signaling Pathway Disruptions Driving Breast Cancer Treatment Resistance

Pharmacy Times

The findings provide a deeper understanding of the mechanisms underlying breast cancer progression and treatment resistance.

article thumbnail

UK sets aside £2m for digitally-enhanced dementia tests

pharmaphorum

The UK is providing 2m in funding to allow digital assessment to be added to a highly-anticipated trial of blood tests for diagnosing dementia

article thumbnail

Long-Term Follow-Up Data from the CASSIOPEIA Trial Show Continued MRD, PFS Benefit in Multiple Myeloma

Pharmacy Times

Adding daratumumab improved minimal residual disease (MRD) negativity rates, leading to superior progression-free survival (PFS).

article thumbnail

Fierce Healthcare - Untitled Article

Fierce Healthcare

Dual-eligible beneficiaries are among the most expensive and complex patients out there. | Pair Team supports community-based organizations via California's Medi-Cal Community Care Hubs model.

article thumbnail

Addressing Drug Shortages: A Call to Action for Pharmacists and Policy Makers

Pharmacy Times

Managing the challenge requires a multifaceted approach with all stakeholders.

article thumbnail

Hubs East 2025: Navigating Specialty Medication Onboarding

Pharmaceutical Commerce

Jen Butler, chief commercial officer, Pleio, discusses how the companys GoodStart programs help patients navigate specialty pharmacies.

article thumbnail

48-Week Data Show Efficacy of Valbenazine in Patients With Tardive Dyskinesia and Schizophrenic, Mood Disorders

Pharmacy Times

About 59.2% of patients with tardive dyskinesia (TD) who completed the 48-week trial achieved remission.

article thumbnail

AstraZeneca Financially Commits $2.5B Toward New R&D Center

Pharmaceutical Commerce

The Beijing location represents the sixth worldwide.